Myles Minter
Stock Analyst at William Blair
(1.97)
# 3,126
Out of 5,132 analysts
23
Total ratings
52.94%
Success rate
2.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Market Perform | n/a | $11.17 | - | 2 | Nov 13, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $11.36 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $1.87 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $47.40 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.91 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $3.85 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $821.96 | - | 2 | Nov 1, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $3.20 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $7.21 | +884.74% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $42.23 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $491.47 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $317.25 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.15 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $314.40 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $80.63 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $124.12 | -6.54% | 1 | Feb 24, 2020 |
Korro Bio
Nov 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.17
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.36
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $1.87
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $47.40
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.91
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $3.85
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $821.96
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $3.20
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $7.21
Upside: +884.74%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $42.23
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $491.47
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $317.25
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.15
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $314.40
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $80.63
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $124.12
Upside: -6.54%